These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38066695)

  • 21. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of monoamine oxidase by benzoxathiolone analogues.
    Mostert S; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1200-4. PubMed ID: 26821818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells.
    Fitzgerald JC; Ufer C; De Girolamo LA; Kuhn H; Billett EE
    J Neurochem; 2007 Dec; 103(6):2189-99. PubMed ID: 17883400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis.
    Cesura AM; Gottowik J; Lahm HW; Lang G; Imhof R; Malherbe P; Röthlisberger U; Da Prada M
    Eur J Biochem; 1996 Mar; 236(3):996-1002. PubMed ID: 8665924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B.
    Oh JM; Kang Y; Hwang JH; Park JH; Shin WH; Mun SK; Lee JU; Yee ST; Kim H
    Int J Biol Macromol; 2022 Sep; 217():910-921. PubMed ID: 35908673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Screening of a Lactobacillus casei with monoamine oxidase-inhibitory activity].
    Wang H; Guo B; Wu Z; Wang Y
    Wei Sheng Wu Xue Bao; 2010 Feb; 50(2):197-203. PubMed ID: 20387462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benextramine and derivatives as novel human monoamine oxidases inhibitors: an integrated approach.
    Di Paolo ML; Cozza G; Milelli A; Zonta F; Sarno S; Minniti E; Ursini F; Rosini M; Minarini A
    FEBS J; 2019 Dec; 286(24):4995-5015. PubMed ID: 31291696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoamine oxidase inhibitory activity in tobacco particulate matter: Are harman and norharman the only physiologically relevant inhibitors?
    Truman P; Grounds P; Brennan KA
    Neurotoxicology; 2017 Mar; 59():22-26. PubMed ID: 28057462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
    Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
    ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing monoamine oxidase B inhibitory activity via chiral fluorination: Structure-activity relationship, biological evaluation, and molecular docking study.
    Wang Z; Yi C; Chen K; Wang T; Deng K; Jin C; Hao G
    Eur J Med Chem; 2022 Jan; 228():114025. PubMed ID: 34871839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect.
    Kumar S; Oh JM; Prabhakaran P; Awasti A; Kim H; Mathew B
    Sci Rep; 2024 Jan; 14(1):1264. PubMed ID: 38218887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B.
    Raddatz R; Parini A; Lanier SM
    J Biol Chem; 1995 Nov; 270(46):27961-8. PubMed ID: 7499273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of monoamine oxidase by selected phenylalkylcaffeine analogues.
    Petzer A; Grobler P; Bergh JJ; Petzer JP
    J Pharm Pharmacol; 2014 May; 66(5):677-87. PubMed ID: 24313346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyrimido[1,2-b]indazole derivatives: Selective inhibitors of human monoamine oxidase B with neuroprotective activity.
    Jismy B; El Qami A; Pišlar A; Frlan R; Kos J; Gobec S; Knez D; Abarbri M
    Eur J Med Chem; 2021 Jan; 209():112911. PubMed ID: 33071056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson Agents.
    Kumar B; Kumar M; Dwivedi AR; Kumar V
    ChemMedChem; 2018 Apr; 13(7):705-712. PubMed ID: 29534334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors.
    Kumar B; Sheetal ; Mantha AK; Kumar V
    Bioorg Chem; 2018 Apr; 77():252-262. PubMed ID: 29421700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats.
    Bar-Am O; Weinreb O; Amit T; Youdim MB
    J Mol Neurosci; 2009 Feb; 37(2):135-45. PubMed ID: 18751929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromenylchalcones with inhibitory effects on monoamine oxidase B.
    Jo G; Ahn S; Kim BG; Park HR; Kim YH; Choo HA; Koh D; Chong Y; Ahn JH; Lim Y
    Bioorg Med Chem; 2013 Dec; 21(24):7890-7. PubMed ID: 24169316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.
    Naoi M; Riederer P; Maruyama W
    J Neural Transm (Vienna); 2016 Feb; 123(2):91-106. PubMed ID: 25604428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells.
    Nagatsu T; Sawada M
    J Neural Transm Suppl; 2006; (71):53-65. PubMed ID: 17447416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.